Skip to content

Driving Consistency, Visibility, and Access: How a Central Repository Powers Active Cancer Clinical Trials

Driving Consistency, Visibility, and Access: How a Central Repository Powers Active Cancer Clinical Trials


Case Studies

Supporting Pancreatic Cancer Research and Clinical Trials

Biospecimen samples across the Pancreatic Cancer Early Detection (PRECEDE) Consortium are used in research and longitudinal studies. As this open global initiative rapidly grew, it needed a way to standardize sample collection, storing, and repurposing protocols without compromising on ease of collaborator access.

Azenta Life Sciences worked closely with PRECEDE to develop and implement a multi-faceted solution that included biospecimen sample collection optimization, centralized storage, detailed tracking, and responsive logistics.

Learn how the PRECEDE Consortium relies on Azenta Life Sciences to manage the world’s largest collection of high-risk pancreatic cancer biospecimens.

Driving Consistency, Visibility, and Access: How a Central Repository Powers Active Cancer Clinical Trials